MeSH term
Frequency | Condition_Probility | Child | 5 | 0.0 |
DNA-Binding Proteins/*genetics | 9 | 0.0 |
Down Syndrome/*complications/*genetics | 2 | 50.0 |
Humans | 50 | 0.0 |
Mutation | 8 | 0.0 |
Risk Factors | 2 | 0.0 |
Transcription Factors/*genetics | 9 | 0.0 |
Prognosis | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 37 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 19 | 0.0 |
Female | 18 | 0.0 |
Infant, Newborn | 8 | 0.0 |
Leukemia, Megakaryocytic, Acute/etiology/*genetics | 3 | 100.0 |
Male | 21 | 0.0 |
Phenotype | 3 | 0.0 |
Acute Disease | 5 | 0.0 |
Adult | 8 | 0.0 |
Aged | 3 | 0.0 |
Base Sequence | 18 | 0.0 |
DNA Primers | 4 | 0.0 |
DNA-Binding Proteins/*metabolism | 3 | 0.0 |
Middle Aged | 3 | 0.0 |
Transcription Factors/*metabolism | 3 | 0.0 |
Tretinoin/*pharmacology | 2 | 0.0 |
Alleles | 3 | 0.0 |
Animals | 23 | 0.0 |
DNA/metabolism | 3 | 0.0 |
Genotype | 2 | 0.0 |
In Situ Hybridization | 4 | 0.0 |
Linkage (Genetics) | 4 | 0.0 |
Mice | 17 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Protein Binding | 5 | 0.0 |
Trans-Activation (Genetics) | 4 | 0.0 |
Transcription Factors/metabolism/*physiology | 2 | 2.0 |
Tumor Cells, Cultured | 7 | 0.0 |
Binding Sites/genetics | 2 | 0.0 |
DNA/genetics/metabolism | 2 | 0.0 |
DNA-Binding Proteins/metabolism | 4 | 0.0 |
K562 Cells | 5 | 1.0 |
Molecular Sequence Data | 21 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Sequence Homology, Nucleic Acid | 4 | 0.0 |
Transcription Factors/metabolism | 4 | 0.0 |
Amino Acid Substitution | 3 | 0.0 |
Anemia, Dyserythropoietic, Congenital/*genetics | 2 | 50.0 |
Gene Expression | 4 | 0.0 |
Heterozygote | 2 | 0.0 |
Infant | 5 | 0.0 |
Thrombocytopenia/*genetics | 2 | 15.0 |
Zinc Fingers | 3 | 0.0 |
Growth Substances/pharmacology | 2 | 1.0 |
Mice, Transgenic | 2 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Signal Transduction | 2 | 0.0 |
Trans-Activators/metabolism | 2 | 0.0 |
Comparative Study | 9 | 0.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Gene Expression Regulation, Developmental | 4 | 0.0 |
Transcription Factors/genetics | 2 | 0.0 |
Vascular Endothelial Growth Factor A | 2 | 0.0 |
Vascular Endothelial Growth Factors | 2 | 0.0 |
DNA Mutational Analysis | 3 | 0.0 |
Erythrocytes/pathology | 2 | 12.0 |
Haplotypes | 2 | 0.0 |
Pedigree | 2 | 0.0 |
*X Chromosome | 6 | 0.0 |
Zinc Fingers/genetics | 2 | 1.0 |
Cell Line | 6 | 0.0 |
DNA Primers/genetics | 2 | 0.0 |
Gene Expression Regulation, Enzymologic | 3 | 0.0 |
Tissue Distribution | 4 | 0.0 |
Transfection | 5 | 0.0 |
Genes, Reporter | 2 | 0.0 |
*Mutation | 5 | 0.0 |
*Promoter Regions (Genetics) | 4 | 0.0 |
Uroporphyrinogen III Synthetase/*genetics | 3 | 37.0 |
DNA/chemistry/genetics | 2 | 0.0 |
DNA, Complementary/chemistry/genetics | 2 | 0.0 |
Exons | 4 | 0.0 |
Introns | 3 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 5 | 0.0 |
Sequence Analysis, DNA | 4 | 0.0 |
Transcription, Genetic | 5 | 0.0 |
Chromosome Mapping | 8 | 0.0 |
DNA | 2 | 0.0 |
Promoter Regions (Genetics) | 6 | 0.0 |
RNA, Messenger/genetics | 4 | 0.0 |
Acetylation | 2 | 0.0 |
Amino Acid Sequence | 4 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Cells, Cultured | 3 | 0.0 |
English Abstract | 2 | 0.0 |
Transcription Factors/*physiology | 2 | 0.0 |
DNA-Binding Proteins/*biosynthesis/genetics | 2 | 2.0 |
Transcription Factors/*biosynthesis/genetics | 2 | 2.0 |
Child, Preschool | 5 | 0.0 |
Genetic Markers | 2 | 0.0 |
*Oligonucleotide Array Sequence Analysis | 2 | 1.0 |
Cloning, Molecular | 3 | 0.0 |
DNA-Binding Proteins/*genetics/metabolism | 2 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
*Proto-Oncogene Proteins | 4 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Cell Transformation, Neoplastic | 2 | 0.0 |
Down Syndrome/*complications/genetics | 2 | 33.0 |
Cell Differentiation | 3 | 0.0 |
Hamsters | 2 | 0.0 |
Species Specificity | 3 | 0.0 |
Cell Differentiation/drug effects | 2 | 0.0 |
Conserved Sequence | 2 | 0.0 |
*Erythropoiesis | 2 | 2.0 |
Crosses, Genetic | 4 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Gene Deletion | 2 | 0.0 |
Bone Marrow/pathology | 2 | 0.0 |
Down Syndrome/complications/*genetics | 3 | 37.0 |
Leukemia, Megakaryocytic, Acute/complications/*genetics | 2 | 66.0 |
*Gene Expression Regulation | 2 | 0.0 |
Alternative Splicing | 2 | 0.0 |
Genetic Predisposition to Disease | 2 | 0.0 |
